[144] Palantir Technologies Inc. SEC Filing

Rhea-AI Filing Summary

Palantir Technologies Inc. (PLTR) Form 144 shows a proposed sale of 9,000 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $1,514,970.00, scheduled approximately for 09/18/2025 on NASDAQ. The shares were acquired on 04/12/2006 through previously exercised stock options and payment was made in cash. The filer’s past three-month reported sales include 21,000 shares sold on 09/11/2025 for $3,484,866.10 (10b5-1 for DAVID STAT) and 800 shares sold on 07/09/2025 for $111,688.00 (10b5-1 for LAUREN STAT). Several standard fields such as the filer CIK/CCC and the filer’s stated relationship to the issuer are not provided in the visible content.

Positive

• Planned sale size is small relative to total shares outstanding, implying limited market impact
• Broker identified as Morgan Stanley Smith Barney LLC, indicating use of an established execution venue
• Acquisition details provided (date and method: exercised options on 04/12/2006) which supports Rule 144 eligibility

Negative

• Key filer identifiers such as CIK/CCC and explicit relationship to the issuer are not provided in the visible content
• Filing lacks full contact and signature details in the provided excerpt, reducing completeness for compliance verification

Insights

Securities Compliance Analyst

TL;DR: Notice of intended sale of 9,000 PLTR shares by a prior option holder; prior 10b5-1 dispositions also disclosed.

The filing is a routine Form 144 disclosing a proposed sale under Rule 144. It documents acquisition by previously exercised options in 2006 and identifies Morgan Stanley Smith Barney as the executing broker. The inclusion of recent 10b5-1 sales for two named sellers provides context on insider or affiliate activity in the past three months. Missing identifiers such as filer CIK/CCC and explicit relationship to the issuer limit completeness for compliance tracking but do not change the basic disclosure of the planned sale.

Equity Trading Specialist

TL;DR: Small planned sale relative to total outstanding shares; market impact likely negligible.

The proposed 9,000-share sale represents a very small fraction of the reported 2,274,261,581 shares outstanding, implying minimal market impact. Recent 10b5-1 executions reported include a larger 21,000-share sale yielding roughly $3.48 million, indicating active systematic insider liquidity. Broker choice is a major retail/institutional dealer, consistent with orderly execution. The filing provides necessary transaction history but lacks certain filer identifiers which are useful for trade surveillance.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	9000	1514970.00	2274261581	09/18/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/12/2006	Previously Exercised Stock Options	Issuer			9000	04/12/2006	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DAVID STAT 1200 17th Street, Floor 15 Denver CO 80202	Common	09/11/2025	21000	3484866.10
10b5-1 Sales for LAUREN STAT 1200 17th Street, Floor 15 Denver CO 80202	Common	07/09/2025	800	111688.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the PLTR Form 144 disclose?

The Form 144 discloses a proposed sale of 9,000 Palantir common shares through Morgan Stanley Smith Barney with aggregate market value $1,514,970.00, planned for 09/18/2025 on NASDAQ.

How were the 9,000 PLTR shares acquired?

The 9,000 shares were acquired on 04/12/2006 through previously exercised stock options and payment was made in cash.

Were there recent insider or affiliate sales for PLTR reported in the filing?

Yes. The filing reports 10b5-1 sales: 21,000 shares sold on 09/11/2025 for $3,484,866.10 (DAVID STAT) and 800 shares sold on 07/09/2025 for $111,688.00 (LAUREN STAT).

Does the filing indicate the seller’s relationship to Palantir?

The provided content does not state the filer’s relationship to the issuer; that information is not present in the excerpt.

What is the number of Palantir shares outstanding reported in the form?

The filing shows 2,274,261,581 shares outstanding.